Title |
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy
|
---|---|
Published in |
Cancer Management and Research, December 2019
|
DOI | 10.2147/cmar.s208720 |
Pubmed ID | |
Authors |
Pamela Munster, Monica Mita, Amit Mahipal, John Nemunaitis, Christophe Massard, Tom Mikkelsen, Cristina Cruz, Luis Paz-Ares, Manuel Hidalgo, Dana Rathkopf, George Blumenschein, David C Smith, Barbara Eichhorst, Tim Cloughesy, Ellen H Filvaroff, Shaoyi Li, Heather Raymon, Hans de Haan, Kristen Hege, Johanna C Bendell |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 59 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 8 | 14% |
Researcher | 5 | 8% |
Student > Bachelor | 5 | 8% |
Student > Master | 4 | 7% |
Other | 3 | 5% |
Other | 12 | 20% |
Unknown | 22 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 22% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 7% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Business, Management and Accounting | 2 | 3% |
Neuroscience | 2 | 3% |
Other | 6 | 10% |
Unknown | 30 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2019.
All research outputs
#12,923,767
of 23,301,510 outputs
Outputs from Cancer Management and Research
#425
of 2,021 outputs
Outputs of similar age
#201,488
of 460,445 outputs
Outputs of similar age from Cancer Management and Research
#16
of 98 outputs
Altmetric has tracked 23,301,510 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,021 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 460,445 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.